# The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients

> **NCT06004843** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Hypoxia
- Hysteroscopy
- Overweight or Obesity

## Interventions

- **DRUG:** remimazolam
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT06004843
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2026-02
- **Final completion:** 2026-04
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004843, "The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06004843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*